Reference Medicine

Sanguine Biosciences

This company provides human biospecimens and patient data to researchers and pharmaceutical companies to support drug discovery and cell therapy development.

OncoPrecision

The company develops patient-derived micro-avatar models and therapeutic antibodies to provide oncology drug discovery and precision medicine services for pharmaceutical partners and clinicians.

Foundation Medicine

This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Precision for Medicine

This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.